DURHAM — Biotech startup InSoma Bio has raised $202,000 in security, according to a filing with the US Securities and Exchange Commission.
Seven investors contributed to the round, which kicked off on June 24.
Stefan Roberts, its chief scientific officer, signed the filing. His LinkedIn page names him as a research scientist at Duke University.
Founded in 2018, the Durham-based startup is a developer of protein-based materials created to address biological wounds and soft tissue.
According to its website, it specializes in research and development of genetically protein-based materials to mimic those naturally found in this environment, further modifying these proteins to assemble only with body heat allowing complex cellular environments created with simple solution injections.